Radiation therapy for intrathoracic recurrence of non-small cell lung cancer

• Published in: American journal of clinical oncology Vol. 20; no. 1; p. 46
• Main Authors: Emami, B, Graham, M V, Deedy, M, Shapiro, S, Kucik, N
• Format: Journal Article
• Language: English
• Published: United States 01.02.1997
• Subjects: Carcinoma, Non-Small-Cell Lung - radiotherapy; Humans; Lung Neoplasms - radiotherapy; Neoplasm Recurrence, Local - radiotherapy; Radiotherapy Dosage; Remission Induction; Survival Analysis; Treatment Failure
• ISSN: 0277-3732; 1537-453X
• DOI: 10.1097/00000421-199702000-00010

Fifty-two of 2,315 patients (2.4%) with non-small cell lung cancer (NSLC) treated with radiation therapy at the Mallinckrodt Institute of Radiology and St. Luke's Hospital between 1975 and 1988 presented with local recurrence after definitive surgery. No patient received radiation therapy after surgery as part of initial treatment and none had evidence of distant metastases at the time of local recurrence. The median time to first recurrence was 14 months. At recurrence, patients presented with disease in the bronchial stump (eight patients), ipsilateral lung parenchyma (10), chest wall (six), regional lymph nodes (five), or some combination thereof (23). Sixty-five percent of patients had histologic evidence of recurrence. Radiation therapy consisted of > 5,000 cGy in conventional fractionation to areas of gross disease in 35 of 52 patients. Of 15 patients receiving > 6,000 cGy, 13 had a favorable--complete (CR) or partial (PR) response--tumor response to radiation therapy. Among these patients, local control was achieved in 70% of patients with marginal recurrences (i.e., stump, parenchyma, or chest wall) and in 50% with nodal recurrences. The median survival after radiation therapy for all patients was 8.5 months. The best indicators for long-term survival were the interval from initial surgery to first recurrence and tumor response to radiation therapy.